Pacira BioSciences, Inc. (PCRX)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	700,966	694,957	690,310	681,754	674,978	665,689	669,229	669,173	666,823	654,062	614,318	580,497	541,533	510,887	500,649	440,564	427,221	421,097	408,298	435,397
Total assets	US$ in thousands	1,553,520	1,521,690	1,646,820	1,583,320	1,574,390	1,534,460	1,542,380	1,523,420	1,681,200	1,734,360	1,733,990	1,891,480	2,075,350	1,356,000	1,325,830	1,287,550	1,274,510	1,220,270	866,111	821,379
Total asset turnover		0.45	0.46	0.42	0.43	0.43	0.43	0.43	0.44	0.40	0.38	0.35	0.31	0.26	0.38	0.38	0.34	0.34	0.35	0.47	0.53

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $700,966K ÷ $1,553,520K
= 0.45

Total asset turnover measures how efficiently a company is using its assets to generate revenue. A higher total asset turnover indicates better utilization of assets. Pacira BioSciences, Inc.'s total asset turnover has fluctuated over the years. It was below 0.5 for the period from March 31, 2020, to June 30, 2021, indicating lower efficiency in utilizing its assets to generate revenue during that time. However, from September 30, 2021, to December 31, 2024, the total asset turnover gradually improved and ranged between 0.38 and 0.46. This suggests the company became more effective in generating revenue relative to its total assets during this period. Overall, Pacira BioSciences, Inc. showed variability in its total asset turnover but demonstrated improvement in asset utilization efficiency in the later periods.